https://www.techtransfer.nih.gov/tech/tab-3071
Capsid-Free AAV Vectors for Gene Delivery and Their Use for Gene Therapy | Technology Transfer
https://www.natap.org/2017/AASLD/AASLD_71.htm
Antiviral Characterization of a Next Generation Chemical Series of HBV Capsid Inhibitors In Vitro...
https://researchdata.gla.ac.uk/1020/
Analysis of the Zika virus capsid-Aedes aegypti mosquito interactome reveals pro-viral host factors...
https://www.sangamo.com/presentation/presentation-a-highly-potent-engineered-aav-capsid-stac-150-enables-high-throughput-aav-production-and-arrayed-epigenetic-regulator-screening-directly-in-cultured-neurons/
Presentation: A Highly Potent Engineered AAV Capsid, STAC-150, Enables High-Throughput AAV...
highly potent
https://www.pharmafocusamerica.com/researchinsights/discovery-of-bimodal-hepatitis-b-virus-ribonuclease-h-and-capsid-assembly
Discovery of bimodal hepatitis B virus ribonuclease H and capsid assembly inhibitors
Hepatitis B virus (HBV) ribonuclease H (RNaseH) inhibitors are a potent class of antivirals that prevent degradation of the viral pregenomic RNA during reverse...
hepatitis b virusdiscovery of
https://www.techtransfer.nih.gov/patent/e-253-1993-0-us-02
SELF-ASSEMBLING RECOMBINANT PAPILLOMAVIRUS CAPSID PROTEINS | Technology Transfer
selfassemblingrecombinantpapillomaviruscapsid
https://www.medcko.com/shop/0513-cabt-b8761-1mg-anti-norovirus-vlp-major-capsid-protein-of-gi-and-gii-monoclonal-antibody-clone-c2049n-1mg-37630
Anti-Norovirus (VLP major capsid protein of GI and GII) monoclonal antibody, clone C2049N - 1mG. |...
https://www.viral-capsid.com/2018/04/18/s-confirmed-the-proximity-of-the-hinge-domains-of-smc2-and-2/
S confirmed the proximity of the hinge domains of SMC2 and | Viral capsid-viral-capsid.com
Apr 18, 2018 - S confirmed the proximity of the hinge domains of SMC2 and SMC4. The globular domains were found not cross-linked to the middle of the coiled-coils, but only...
https://www.mybeckman.se/resources/reading-material/posters/quantification-of-aav-capsid-loading-fractions
Quantification of AAV Capsid Loading Fractions
Gene therapy has the potential to treat a wide range of diseases from cancer to cardiovascular disorders. Recombinant Adeno Associated Virus (rAAV) vectors are...
quantificationaavcapsidloadingfractions
https://mro.massey.ac.nz/items/11828453-e40e-45bb-b699-f1bfdddadf6c
Elimination of Leishmania RNA virus from Leishmania spp. via expression of homologous viral capsid...
Leishmaniasis is a neglected tropical disease caused by the protozoan parasite Leishmania with complex pathology ranging from skin ulcers to fatal organ...
rna virus
https://www.natap.org/2016/AASLD/AASLD_132.htm
The HBV capsid inhibitor AB-423 exhibits a dual mode of action and displays additive/synergistic...
https://digitalcommons.unl.edu/virologypub/189/
"Evolutionary and Structural Analyses of Alpha-Papillomavirus Capsid Pr" by John Lowe, Debasis...
Background: PVs (PV) are small, non-enveloped, double-stranded DNA viruses that have been identified as the primary etiological agent for cervical cancer and...
https://www.pirbright.ac.uk/publications/foot-and-mouth-disease-vaccines-design-production-capsid-modified-foot-and-mouth
Foot-and-Mouth Disease Vaccines by Design; Production of Capsid-Modified Foot-and-Mouth Disease...
Nov 10, 2025 - Background/objectives: Vaccination is important for controlling foot-and-mouth disease (FMD) in endemic regions and to lessen the effects of outbreaks in...
foot and mouth diseaseby designvaccines
https://www.solidbio.com/publication/novel-aav-capsid-identification-and-characterization-for-neuromuscular-and-cardiac-indications/
Novel AAV Capsid Identification and Characterization for Neuromuscular and Cardiac Indications -...
novelaavcapsididentificationcharacterization
https://www.viral-capsid.com/2018/07/27/4865/
E provide: advantageous vs. disadvantageous) | Viral capsid-viral-capsid.com
Jul 27, 2018 - E provide: advantageous vs. disadvantageous)
evsviralcapsid
https://www.labor-poing.de/detail/ebv-capsid-antigen-igg-vca-igg/
EBV-Capsid-Antigen-IgG (VCA-IgG) - MVZ Labor Poing
ebvcapsidantigeniggvca
https://biobriefs.com/autonomous-funding-latus-bio-series
Autonomous funding: Latus Bio series A for AAV capsid platform | BioBriefs
May 5, 2026 - Latus Bio closed a $97 million Series A to advance a therapeutics pipeline built around novel AAV capsid variants, funding operations through milestones tied...
bio seriesautonomousfunding
https://www.rcsb.org/structure/5IRT
RCSB PDB - 5IRT: Dimerization interface of the noncrystalline HIV-1 capsid protein lattice from...
Dimerization interface of the noncrystalline HIV-1 capsid protein lattice from solid state NMR spectroscopy of tubular assemblies
https://pubchem.ncbi.nlm.nih.gov/protein/Q81023
Minor capsid protein L2 (Human papillomavirus type 54) | Protein Target - PubChem
Protein target information for Minor capsid protein L2 (Human papillomavirus type 54). Find diseases associated with this biological target and compounds...
human papillomavirusminorcapsidproteintype
https://www.natap.org/2017/AASLD/AASLD_45.htm
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-56136379, a Novel HBV Capsid...
https://pure.korea.ac.kr/en/publications/production-of-human-papillomavirus-type-33-l1-major-capsid-protei/
Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from...
https://www.cytivalifesciences.com/en/us/training/training-catalog/object/course-5534433
How to optimize AAV capsid separation | Cytiva
Viral vector production, AAV full and empty capsid separation, protocol for AAV polishing, Adeno-associated virus, downstream, chromatograph
how to optimizeaavcapsidseparationcytiva
https://sciety.org/articles/activity/10.21203/rs.3.rs-9396596/v1
In Silico Discovery of Potential Antiviral Leads Targeting the Canine Parvovirus Type 2 VP2 Capsid...
0 evaluations Latest version Apr 14, 2026
https://www.viral-capsid.com/2018/04/16/by-mixing-the-reaction-mixture-with-an-equal-volume-of-2x-3/
By mixing the reaction mixture with an equal volume of 2x | Viral capsid-viral-capsid.com
Apr 16, 2018 - By mixing the reaction mixture with an equal volume of 2x nonreducing SDS-sample buffer containing 10 mM EDTA. Samples were analyzed by SDS-PAGE, followed by...
https://www.mdaconference.org/abstract-library/immune-response-to-aav-vector-capsid-and-assessment-of-eligibility-for-aav-mediated-gene-therapy-for-duchenne-muscular-dystrophy/
Immune response to AAV Vector Capsid and Assessment of Eligibility for AAV-mediated Gene therapy...
Feb 27, 2023 - The field of gene therapy still faces a challenge of the host immune response against capsid proteins. We hypothesize that our proposed immunosuppression...
https://caslab.com/anti-norovirus-capsid-protein-vp1-gentaur/
Anti-NoroVirus Capsid protein VP1 | 513-DPATB-H83575
Anti-NoroVirus Capsid protein VP1 Manufactured by Gentaur. Gentaur is the biggest antibody manufacturer worldwide.
antinoroviruscapsidprotein
https://www.packgene.com/news/packgene-to-present-advances-in-scalable-aav-manufacturing/
PackGene to Present Advances in Scalable AAV Manufacturing, Analytical Innovation, and Novel Capsid...
May 5, 2026 - Six presentations highlight advances in cell line development, novel AAV capsid engineering, upstream and downstream process optimization, and quality
https://digitalcommons.mtu.edu/michigantech-p/17056/
"Empty and Full AAV Capsid Charge and Hydrophobicity Differences Measur" by Caryn L. Heidt,...
Adeno-associated virus (AAV) is showing promise as a therapy for diseases that contain a single-gene deletion or mutation. One major scale-up challenge is the...
https://www.products.nanoexpo.eu/produkt/major-capsid-protein-vp1-gii-17/
Major capsid protein VP1 GII.17 - Virology Research Essentials - NanoExpo
research essentialsmajorcapsidproteinvirology
https://pubmed.ncbi.nlm.nih.gov/36385533/
Direct activation of a bacterial innate immune system by a viral capsid protein
innate immune systemdirect activation
https://pmc.ncbi.nlm.nih.gov/articles/PMC2652759/
Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsid - PMC
Minor coat protein IIIa is conserved in all adenoviruses and required for correct viral assembly, but its precise function in capsid organization is unknown....
https://www.proquest.com/docview/304842834
Modification of adenovirus capsid proteins for gene therapy applications - ProQuest
Explore millions of resources from scholarly journals, books, newspapers, videos and more, on the ProQuest Platform.
gene therapymodificationadenoviruscapsidproteins
https://www.addgene.org/browse/article/1916/
Addgene: Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1...
https://www.fiercebiotech.com/biotech/novartis-ignites-new-stage-voyager-pact-15m-capsid-deal
Novartis ignites new stage of Voyager pact with $15M capsid deal
Sep 5, 2024 - Novartis is paying Voyager $15 million to take up its option on a novel capsid for use in a rare neurological disease gene therapy program.
new stagenovartis
https://www.viral-capsid.com/2018/03/14/n-picture-naming-of-cognates-a-test-on-l-and-l/
N picture naming of cognates, a test on L and L | Viral capsid-viral-capsid.com
Mar 14, 2018 - N picture naming of cognates, a test on L and L oral cognate naming in the course of fMRI scanning was performed. Participants were instructed to respect...
https://www.ncbi.nlm.nih.gov/Structure/pdb/1C8D
1C8D: CANINE PANLEUKOPENIA VIRUS EMPTY CAPSID STRUCTURE
CANINE PARVOVIRUS CAPSIDCALCIUM ION
caninepanleukopeniavirusemptycapsid
https://pure.ulster.ac.uk/en/publications/capsid-engineering-overcomes-barriers-toward-adeno-associated-vir/
Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of...
capsid engineering